Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-07-30
2009-06-30
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S315000, C544S358000, C546S184000
Reexamination Certificate
active
07553837
ABSTRACT:
The present invention is directed to compounds represented by the formula (1): B-D-Z (1), wherein B represent the following formula (B-1), (B-2) or (B-3);A represents an optionally substituted imidazole or pyrazole group;E represents the following formula (1a);X represents an oxygen atom, the formula: SOu, or the formula: N—R9;Y represents a carbon atom or a nitrogen atom;D represents an oxygen atom, a sulfur atom or the formula (1a);Z represents (a chroman-2-yl group, a chroman-4-yl group, a 2,3-dihydrobenzofuran-2-yl group, a 2,3-dihydrobenzofuran-3-yl group, etc.) which is substituted with NHR10or OR11)] or pharmaceutically acceptable salts thereof, and to antioxidants, therapeutic agents for kidney diseases or cerebrovascular disorder, and retinal oxidative damage inhibitors, which include the compounds as the active ingredient.
REFERENCES:
patent: 4006243 (1977-02-01), Strehlke et al.
patent: 4301169 (1981-11-01), Yamanaka et al.
patent: 5376681 (1994-12-01), Aono et al.
patent: 5393775 (1995-02-01), Le Baut et al.
patent: 5552552 (1996-09-01), Ohkawa et al.
patent: 5859181 (1999-01-01), Zhao et al.
patent: 3407505 (1985-09-01), None
patent: 1101759 (2001-05-01), None
patent: 2267101 (1975-04-01), None
patent: 55-69567 (1980-05-01), None
patent: 2-121975 (1990-05-01), None
patent: 5-140142 (1993-06-01), None
patent: 6-192248 (1994-07-01), None
patent: 6-228136 (1994-08-01), None
patent: 9-176157 (1997-07-01), None
patent: WO-87/05020 (1987-08-01), None
patent: WO-95/29163 (1995-11-01), None
patent: WO-96/28437 (1996-09-01), None
patent: WO9957113 (1999-11-01), None
patent: WO-00/06550 (2000-02-01), None
Warner. Expert Opinion in Therapeutic Patents, 2000, 10(2), 245-49.
Martignoni et al. Expert Opinion in Drug Metabolism and Toxicology, 2006, 2(6), 875-94.
“Neuroleptic Activity in 5-Aryltetrapydro-γ-carbolines” by Harbert et al., Journal of Medicinal Chemistry, Jun. 1980, vol. 23, No. 6, pp. 635-643.
“Pyridine Hydrochloride-Catalyzed Fischer Indole Reactions” by Welch, Synthesis—International Journal of Methods in Synthetic Organic Chemistry, Sep. 1977, No. 9, pp. 645-646.
“Synthesis of Some Conformationally Restricted Analogues of Fentanyl1”, by Berger et al., Journal of Medicinal Chemistry, vol. 20, Apr. 1977, No. 4, pp. 600-602.
“Lipid Peroxidation in Liver: Hydroxy Dimethyl Carbazole, A New Potent Inhibitor” by Malvy, et al., Biochemical and Biophysical Research Communications, vol. 95, No. 2, Jul. 31, 1980, pp. 734-737.
“5-Aminocoumarans: Dual Inhibitors of Lipid Peroxidation and Dopamine Release with Protective Effects against Central Nervous System Trauma and Ischemia” by Ohkawa et al., Journal of Medicinal Chemistry, Feb. 14, 1997, vol. 40, No. 4, American Chemical Society, pp. 559-573.
Measurement of Thiobarbituric acid Value in Liver Homogenate Solubilized with Sodium dodecylsulphate and Variation of the Values Affected by Vitamin E and Drugs by Masugi et al., Vitamins (Japan) 51, 1977, pp. 21-29.
“Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4” by Laemmli, Nature, vol. 227, Aug. 15, 1970, pp. 680-685.
“5-Lipoxygenase Inhibitory Activity of Zileuton1” by Carter et al., The Journal of Pharmacology and Experimental Therapeutics, vol. 256, No. 3, Mar. 1991, pp. 929-937.
“A Spectrophotometric Microtiter-Based Assay for the Detection of Hydroperozy Derivatives of Linoleic Acid” by Auerbach, et al., Analytical Biochemistry, vol. 201, No. 2, Mar. 1992, pp. 375-380.
International Search Report for PCT/JP2004/011297 mailed Sep. 21, 2004.
Ikeyama Seiichi
Mochizuki Nobuo
Momoe Hiroko
Shiinoki Yasuyuki
Shirato Fumie
Darby & Darby P.C.
Jarrell Noble
Nippon Soda Co. Ltd.
Wilson James O
LandOfFree
Phenylazole compounds production process and antioxidants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylazole compounds production process and antioxidants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylazole compounds production process and antioxidants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4142969